Thomas Jefferson University & Temple University Enter Exclusive Negotiations
Jefferson has signed an agreement with Temple University to pursue the purchase of the Fox Chase Cancer Center during an exclusive 90-day window.
Together, Jefferson and Temple would provide expert cancer treatments and breakthrough research to improve patient’s lives in Philadelphia and throughout the region. They would also enter into a long-term cancer-related academic affiliation agreement.
A leading center for practice-changing discovery and comprehensive cancer treatment, the Sidney Kimmel Cancer Center of the Thomas Jefferson University has been known as a Designated Center by the National Cancer Institute since 1996, and is one of only 70 institutions in the nation to hold this prestigious recognition. SKCC is committed to delivering the most advanced, personalized cancer care, made possible through their scientific discoveries and breakthroughs in detecting and treating cancer. SKCC provides access to advanced clinical trials and novel treatment strategies throughout the Greater Delaware Valley. SKCC is routinely ranked amongst the top hospitals for cancer care in the United States by US News & World Report, the multi-disciplinary teams at SKCC bring together specialists for treatment planning, which results in some of the highest survival rates in the nation.
At The Sidney Kimmel Cancer Center – Abington Jefferson Health we bring you 86,000 square feet of comprehensive cancer care with everything you need to fight cancer under one roof, in one convenient location.
Find out about the Asplundh Cancer Pavilion >
American Association for Cancer Research Elects SKCC Director Karen Knudsen to Board of Directors
Sidney Kimmel Cancer Center Researchers to Present at AACR Annual Meeting 2019
Eyes on the Prize: Developing Better Treatments for Uveal Melanoma
Colon Cancer: Fact or Fiction?
Dr. Adam Dicker Named ASCO Fellow